Concepedia

Devalingam Mahalingam

DM

Statistics

Publications

76

Citations

4.7K

H-Index

38

Active since

2009

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

Northwestern University

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Oncolytics Biotech (Canada)

Mays Cancer Center at UT Health San Antonio

Devalingam Mahalingam is an author at The University of Texas at San Antonio Health Science Center specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

2009–2025

76

Publications

76

Combined autophagy and HDAC inhibition

Devalingam Mahalingam, Monica Mita, John Sarantopoulos et al. · Autophagy · 2014 · 289 citations · Full text

, , +17

Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia

Ronan Swords, Kevin R. Kelly, Peter G. Smith et al. · Blood · 2010 · 277 citations · Full text

, , +7

Single‐cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT‐related genes in metastatic prostate cancer

Chun‐Liang Chen, Devalingam Mahalingam, Rohit R. Jadhav et al. · The Prostate · 2012 · 234 citations

, , +17

A Phase I, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib (LDE225) in Patients with Advanced Solid Tumors

Jordi Rodón, Hussein Tawbi, Anne Thomas et al. · Clinical Cancer Research · 2014 · 231 citations · Full text

, , +17

Autophagy inhibition enhances vorinostat‐induced apoptosis <i>via</i> ubiquitinated protein accumulation

Jennifer S. Carew, Ernest Medina, Juan Esquivel et al. · Journal of Cellular and Molecular Medicine · 2009 · 221 citations · Full text

, , +17

1–5 of 76